Mavens Biotech Limited, a active public limited company, was established on 24 October 1981 in Kolkata, West Bengal, India. Engaging in agro retail & distribution within the real estate sector, it holds CIN: L17297WB1981PLC034226. Registered under ROC Roc Kolkata. it is listed. It has an authorized capital of ₹13.00 Cr and a paid-up capital of ₹10.99 Cr.
It upholds a compliant status. In 2023, it reported revenue of ₹18.00 K and a net worth of ₹5.43 Cr. Its leadership includes Jay Prakash (Managing Director), Sunita Hanuman Singhi (Director), Biswajit Barua (Director). Past directors included Lalit Garg, Anil Jain, Roopali Singhal. Its latest AGM occurred on 11 August 2025, with the balance sheet filed on 31 March 2025. It is based at Room No. 407, 4Th Floor, Premises No. 4 Clive Row, Kolkata, West Bengal, 700001.
L17297WB1981PLC034226
034226
24 October 1981
₹13.00 Cr
₹10.99 Cr
Roc Kolkata
Listed
Active
Explore comprehensive insights into Mavens Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jay Prakash | Managing Director | 28 Jan 2022 | Current |
| Sunita Hanuman Singhi | Director | 26 Jun 2024 | Current |
| Biswajit Barua | Director | 26 Jul 2023 | Current |
| Manoj Kumar | Director | 01 Oct 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Feb 2011 | Past |
| Pramod Abcsdd | Additional Director | 11 Apr 2011 | Past |
| Pramod Abcsdd | Company Secretary | 11 Apr 2011 | Past |
| Pramod Abcsdd | Director | 20 Mar 2018 | Past |
| Pramod Abcsdd | Whole-Time Director | 02 Dec 2017 | Past |
| Pramod Abcsdd | Director | 29 Sep 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mavens Biotech Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 84.35% decrease. The company also saw a substantial improvement in profitability, with a 113.03% increase in profit. The company's net worth moved up by a moderate rise of 0.34%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Mavens Biotech had a promoter holding of 32.04% and a public holding of 67.96%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Mavens Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mavens Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mavens Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Mavens Biotech Limited last Annual general meeting of members was held on 11 Aug 2025 as per latest MCA records. was recorded as a recent event.
Mavens Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata. was recorded as a recent event.
Sunita Hanuman Singhi was appointed as a Director was appointed as a Director on 26 Jun 2024 & has been associated with this company since 1 year 5 months . was recorded as a recent event.
The activity Jay Prakash was appointed as a Ceo was appointed as a Ceo on 24 Jun 2024 & has been associated with this company since 1 year 5 months . was completed.
Progress on Abhishek Kumar Jain was appointed as a CFO was appointed as a CFO on 04 Aug 2023 & has been associated with this company since 2 years 3 months . was documented.
Biswajit Barua was appointed as a Director was appointed as a Director on 26 Jul 2023 & has been associated with this company since 2 years 4 months . was recorded as a recent event.
The CIN of Mavens Biotech Limited is L17297WB1981PLC034226.
Mavens Biotech Limited is headquartered at Room No. 407, 4Th Floor, Premises No. 4 Clive Row, Kolkata, West Bengal, 700001.
Mavens Biotech Limited was incorporated on 24 October 1981.
The current directors of Mavens Biotech Limited are
The primary industry of Mavens Biotech Limited is Real Estate.
Mavens Biotech Limited is listed.
The authorized capital of Mavens Biotech Limited is ₹13.00 Cr, and the paid-up capital is ₹10.99 Cr.
The compliance status of Mavens Biotech Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX